Stifel Maintains Buy on Adient, Lowers Price Target to $21
Stifel analyst Nathan Janes maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $26 to $21.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga